Global Narcolepsy Treatment Market by Drug Class (CNS Stimulants, Decongestants, Serotonin Reuptake Inhibitors), Narcolepsy Type (Narcolepsy Type 1, Narcolepsy Type 2), Distribution Channel - Forecast 2024-2030- Product Image

Sale

Global Narcolepsy Treatment Market by Drug Class (CNS Stimulants, Decongestants, Serotonin Reuptake Inhibitors), Narcolepsy Type (Narcolepsy Type 1, Narcolepsy Type 2), Distribution Channel - Forecast 2024-2030

Report
186 Pages
March 2024
Region: Global
360iResearch™
ID: 4968747

UP TO €848EUR$875USD£726GBP OFF until Dec 31^st 2024

The Narcolepsy Treatment Market size was estimated at USD 3.86 billion in 2023, USD 4.38 billion in 2024, and is expected to grow at a CAGR of 13.45% to reach USD 9.36 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Narcolepsy Treatment Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Narcolepsy Treatment Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Narcolepsy Treatment Market, highlighting leading vendors and their innovative profiles. These include Addrenex Pharmaceuticals, Inc., Arena Pharmaceuticals, Inc., Avadel Pharmaceuticals plc, Axsome Therapeutics, Inc., GlaxoSmithKline PLC, Graymark Healthcare Inc., Harmony Biosciences LLC, Jazz Pharmaceuticals plc, Johnson & Johnson Services Inc., Ligand Pharmaceuticals, Midas Pharma GmbH, Novartis AG, Pfizer Inc., Shire Plc, and Teva Pharmaceutical Industries Ltd.

Market Segmentation & Coverage

This research report categorizes the Narcolepsy Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

Drug Class
- CNS Stimulants
- Decongestants
- Serotonin Reuptake Inhibitors
- Vasopressors
Narcolepsy Type
- Narcolepsy Type 1
- Narcolepsy Type 2
Distribution Channel
- Drug Stores
- E-commerce
- Retail Pharmacies

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Narcolepsy Treatment Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Narcolepsy Treatment Market?
What are the technology trends and regulatory frameworks in the Narcolepsy Treatment Market?
What is the market share of the leading vendors in the Narcolepsy Treatment Market?
Which modes and strategic moves are suitable for entering the Narcolepsy Treatment Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Narcolepsy Treatment Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing cases of sleep disorder narcolepsy
5.1.1.2. Growing consumer awareness regarding narcolepsy treatment
5.1.1.3. Rising government approvals for narcolepsy therapeutics
5.1.2. Restraints
5.1.2.1. Adverse effects of the narcolepsy treatment
5.1.3. Opportunities
5.1.3.1. Rise in the research activities related to the narcolepsy treatment
5.1.3.2. Emergence of favorable reimbursement policies
5.1.4. Challenges
5.1.4.1. Shortage of medical professionals
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Narcolepsy Treatment Market, by Drug Class

6.1. Introduction
6.2. CNS Stimulants
6.3. Decongestants
6.4. Serotonin Reuptake Inhibitors
6.5. Vasopressors

7. Narcolepsy Treatment Market, by Narcolepsy Type

7.1. Introduction
7.2. Narcolepsy Type 1
7.3. Narcolepsy Type 2

8. Narcolepsy Treatment Market, by Distribution Channel

8.1. Introduction
8.2. Drug Stores
8.3. E-commerce
8.4. Retail Pharmacies

9. Americas Narcolepsy Treatment Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Narcolepsy Treatment Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Narcolepsy Treatment Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

13.1. Key Company Profiles
13.1.1. Addrenex Pharmaceuticals, Inc.
13.1.2. Arena Pharmaceuticals, Inc.
13.1.3. Avadel Pharmaceuticals plc
13.1.4. Axsome Therapeutics, Inc.
13.1.5. GlaxoSmithKline PLC
13.1.6. Graymark Healthcare Inc.
13.1.7. Harmony Biosciences LLC
13.1.8. Jazz Pharmaceuticals plc
13.1.9. Johnson & Johnson Services Inc.
13.1.10. Ligand Pharmaceuticals
13.1.11. Midas Pharma GmbH
13.1.12. Novartis AG
13.1.13. Pfizer Inc.
13.1.14. Shire Plc
13.1.15. Teva Pharmaceutical Industries Ltd.
13.2. Key Product Portfolio

14. Appendix

14.1. Discussion Guide
14.2. License & Pricing

List of Figures

FIGURE 1. NARCOLEPSY TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. NARCOLEPSY TREATMENT MARKET SIZE, 2023 VS 2030
FIGURE 3. NARCOLEPSY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. NARCOLEPSY TREATMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. NARCOLEPSY TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. NARCOLEPSY TREATMENT MARKET DYNAMICS
FIGURE 7. NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2023 VS 2030 (%)
FIGURE 8. NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2023 VS 2030 (%)
FIGURE 10. NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 12. NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. NARCOLEPSY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. NARCOLEPSY TREATMENT MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. NARCOLEPSY TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. NARCOLEPSY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 6. NARCOLEPSY TREATMENT MARKET SIZE, BY CNS STIMULANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. NARCOLEPSY TREATMENT MARKET SIZE, BY DECONGESTANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. NARCOLEPSY TREATMENT MARKET SIZE, BY SEROTONIN REUPTAKE INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. NARCOLEPSY TREATMENT MARKET SIZE, BY VASOPRESSORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
TABLE 11. NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE 1, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE 2, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 14. NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. NARCOLEPSY TREATMENT MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. NARCOLEPSY TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 21. ARGENTINA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 22. ARGENTINA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 24. BRAZIL NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 25. BRAZIL NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 27. CANADA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 28. CANADA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
TABLE 29. CANADA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 30. MEXICO NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 31. MEXICO NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
TABLE 32. MEXICO NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 37. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 38. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 41. AUSTRALIA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 42. AUSTRALIA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
TABLE 43. AUSTRALIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 44. CHINA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 45. CHINA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
TABLE 46. CHINA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 47. INDIA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 48. INDIA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
TABLE 49. INDIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 50. INDONESIA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 51. INDONESIA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
TABLE 52. INDONESIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 53. JAPAN NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 54. JAPAN NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
TABLE 55. JAPAN NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 56. MALAYSIA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 57. MALAYSIA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
TABLE 58. MALAYSIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 59. PHILIPPINES NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 60. PHILIPPINES NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
TABLE 61. PHILIPPINES NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 62. SINGAPORE NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 63. SINGAPORE NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
TABLE 64. SINGAPORE NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 65. SOUTH KOREA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 66. SOUTH KOREA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
TABLE 67. SOUTH KOREA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 68. TAIWAN NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 69. TAIWAN NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
TABLE 70. TAIWAN NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 71. THAILAND NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 72. THAILAND NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
TABLE 73. THAILAND NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 74. VIETNAM NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 75. VIETNAM NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
TABLE 76. VIETNAM NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 81. DENMARK NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 82. DENMARK NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
TABLE 83. DENMARK NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 84. EGYPT NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 85. EGYPT NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
TABLE 86. EGYPT NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 87. FINLAND NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 88. FINLAND NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
TABLE 89. FINLAND NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 90. FRANCE NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 91. FRANCE NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
TABLE 92. FRANCE NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 93. GERMANY NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 94. GERMANY NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
TABLE 95. GERMANY NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 96. ISRAEL NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 97. ISRAEL NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
TABLE 98. ISRAEL NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 99. ITALY NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 100. ITALY NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
TABLE 101. ITALY NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 102. NETHERLANDS NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 103. NETHERLANDS NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
TABLE 104. NETHERLANDS NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 105. NIGERIA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 106. NIGERIA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
TABLE 107. NIGERIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 108. NORWAY NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 109. NORWAY NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
TABLE 110. NORWAY NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 111. POLAND NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 112. POLAND NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
TABLE 113. POLAND NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 114. QATAR NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 115. QATAR NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
TABLE 116. QATAR NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 117. RUSSIA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 120. SAUDI ARABIA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 123. SOUTH AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 126. SPAIN NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 127. SPAIN NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
TABLE 128. SPAIN NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. SWEDEN NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 132. SWITZERLAND NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 133. SWITZERLAND NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
TABLE 134. SWITZERLAND NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 135. TURKEY NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 136. TURKEY NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
TABLE 137. TURKEY NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 138. UNITED ARAB EMIRATES NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 139. UNITED ARAB EMIRATES NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 144. NARCOLEPSY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 145. NARCOLEPSY TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
TABLE 146. NARCOLEPSY TREATMENT MARKET LICENSE & PRICING

Companies Mentioned

Addrenex Pharmaceuticals, Inc.
Arena Pharmaceuticals, Inc.
Avadel Pharmaceuticals plc
Axsome Therapeutics, Inc.
GlaxoSmithKline PLC
Graymark Healthcare Inc.
Harmony Biosciences LLC
Jazz Pharmaceuticals plc
Johnson & Johnson Services Inc.
Ligand Pharmaceuticals
Midas Pharma GmbH
Novartis AG
Pfizer Inc.
Shire Plc
Teva Pharmaceutical Industries Ltd.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	186
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 4.38 Billion
Forecasted Market Value ( USD ) by 2030	$ 9.36 Billion
Compound Annual Growth Rate	13.4%
Regions Covered	Global
No. of Companies Mentioned	15

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3270EUR$3,374USD£2,801GBP €3633EUR$3,749USD£3,112GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4142EUR$4,274USD£3,548GBP €4602EUR$4,749USD£3,942GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5014EUR$5,174USD£4,295GBP €5571EUR$5,749USD£4,772GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5887EUR$6,074USD£5,042GBP €6541EUR$6,749USD£5,602GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7631EUR$7,874USD£6,536GBP €8479EUR$8,749USD£7,262GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Global Narcolepsy Drugs Market (By Therapeutic Type, Disease Type, End User, Regional Analysis), Pipeline Analysis, Key Company Profiles and Recent Developments - Forecast to 2030

Narcolepsy Drugs Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis

Global Narcolepsy Drugs Market by Type (Narcolepsy with Cataplexy, Narcolepsy without Cataplexy, Secondary Narcolepsy), Therapeutics Type (Central Nervous System Stimulants, Selective Serotonin Reuptake Inhibitor, Sodium Oxybate) - Forecast 2024-2030

Global Narcolepsy Drugs Market Report and Forecast 2023-2031

Non Cataplexy Narcolepsy Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type